Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells

Steroids
Richard J SantenWei Yue

Abstract

Activation of IGF-1R can activate metalloproteinases which release heparin-binding EGF (Hb-EGF) and lead to EGFR-dependent MAPK activation in certain tissues. We postulated that this pathway is operative in E(2)-induced MAPK activation in breast cancer tissues. As evidence, we showed that E(2) rapidly induced the phosphorylation of both IGF-1R and EGFR and that siRNA knockdown or selective inhibitors against either growth factor receptor inhibited E(2)-induced MAPK activation. The selective inhibitors or knockdown of either IGF-1R or EGFR significantly inhibited cell growth and reversed cell death protection induced by E(2) in MCF-7 cells. Our data support the conclusion that the IGF-1R acts upstream of EGFR in a linear pathway which mediates E(2) action on MAPK activation, cell growth stimulation and anti-apoptosis in breast cancer cells. During the process of development of tamoxifen resistance this pathway is up-regulated with increased sensitivity to activate EGFR for cell growth and protection against apoptosis. Surprisingly, translocation of ERalpha out of the nucleus into the cytoplasm, mediated by c-Src, occurs during development of resistance. This effect can be abrogated by administration of the c-Src inhibitor, PP2 w...Continue Reading

References

Dec 20, 1990·The Journal of Steroid Biochemistry and Molecular Biology·S NicholsonA L Harris
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·R G RichardsJ Sebastian
Apr 21, 1999·Current Opinion in Cell Biology·L M LuttrellR J Lefkowitz
Apr 21, 1999·Current Opinion in Cell Biology·P O HackelA Ullrich
Nov 30, 1999·Trends in Pharmacological Sciences·E ZwickA Ullrich
Apr 6, 2000·The Journal of Biological Chemistry·S KahlertC Grohe
Oct 19, 2001·Oncogene·K S Ravichandran
Nov 22, 2001·Journal of the National Cancer Institute·R X SongR J Santen
Oct 9, 2003·Breast Cancer Research and Treatment·Iain R HutchesonRobert I Nicholson
Nov 6, 2003·International Journal of Cancer. Journal International Du Cancer·Renato BasergaKrysztof Reiss
Jan 22, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Richard J SantenRakesh Kumar
Feb 7, 2004·Proceedings of the National Academy of Sciences of the United States of America·Robert X SongRichard J Santen
Aug 4, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Vasilia-Ismini AlexakiElias Castanas
Sep 8, 2004·Journal of Cellular Biochemistry·Boris J Cheskis

❮ Previous
Next ❯

Citations

Nov 6, 2013·Biochimica Et Biophysica Acta·Yousef HawsawiJames Beattie
Oct 5, 2010·Annual Review of Medicine·C Kent Osborne, Rachel Schiff
Feb 18, 2014·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Sandra HeskampHanneke W M van Laarhoven
Sep 3, 2014·Breast Cancer Research and Treatment·Yassine RechoumSuzanne A W Fuqua
Oct 13, 2009·Molecular Endocrinology·Baohua ZhangSheng Wang
Nov 30, 2013·Breast Cancer Research : BCR·Suzanne A EcclesAlastair M Thompson
Mar 12, 2010·Breast Cancer Research and Treatment·Lynnette Fernández-CuestaMagali Olivier
Nov 11, 2010·The Journal of Nutritional Biochemistry·Pei-Hsuan ChenChia-Ron Yang
Sep 4, 2010·Seminars in Cell & Developmental Biology·John FoleyDavid J Riese
Jun 16, 2015·Environment International·Ryoiti Kiyama, Yuko Wada-Kiyama
Dec 3, 2014·Molecular and Cellular Endocrinology·Jonna FrasorIrida Kastrati
Aug 5, 2014·Journal of Cellular and Molecular Medicine·Simona CeccarelliCinzia Marchese
Nov 7, 2013·Dermato-endocrinology·M Julie Thornton
Dec 3, 2013·Breast Cancer Research : BCR·Zhiqiang MoGuanglun Yang
Feb 26, 2016·The Journal of Endocrinology·Koen D Flach, Wilbert Zwart
Jun 12, 2016·Biochimica Et Biophysica Acta·Nofrat SchwartzBarbara D Boyan
Mar 14, 2018·Endocrine-related Cancer·Tiago Vieira AugustoCristina Amaral
Nov 23, 2017·Endocrine-related Cancer·Philipp Y MaximovV Craig Jordan
Oct 12, 2018·Endocrinology·Thu H Truong, Carol A Lange
Feb 5, 2011·Molecular Endocrinology·Marc A BeckerDouglas Yee
Nov 1, 2017·Hormone Molecular Biology and Clinical Investigation·Amitabha Ray
Mar 1, 2011·Hormone Molecular Biology and Clinical Investigation·Julia M W GeeIain R Hutcheson
May 1, 2011·Expert Review of Endocrinology & Metabolism·Stephen Hiscox, Robert I Nicholson
Jun 9, 2018·European Journal of Medical Research·Istvan MarczellAttila Patocs
May 1, 2011·Expert Review of Endocrinology & Metabolism·Etienne Leygue, Leigh Murphy

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis